Bimekizumab 4-Year Efficacy in High-Impact Areas in Moderate to Severe Plaque Psoriasis: Pooled Results from BE BRIGHT. J of Skin 2024, 8 (6), s432. https://doi.org/10.25251/skin.8.supp.432.